世界の心臓マーカー市場予測 2021年-2026年

【英語タイトル】Global Cardiac Marker Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9464)・商品コード:LPI21MY9464
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:166
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「心臓マーカーの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クレアチンキナーゼ(CK)MB、トロポニン(cTnI・cTnT)、BNP・NT-proBNP、ミオグロブリン、その他(hs-CRP、D-ダイマー)など、用途別には、心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他などにセグメント区分してまとめました。心臓マーカーのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・心臓マーカーの世界市場概要(サマリー)
・心臓マーカーの企業別販売量・売上
・心臓マーカーの企業別市場シェア
・心臓マーカーの世界市場規模 2016年-2021年:種類別(クレアチンキナーゼ(CK)MB、トロポニン(cTnI・cTnT)、BNP・NT-proBNP、ミオグロブリン、その他(hs-CRP、D-ダイマー))
・心臓マーカーの世界市場規模 2016年-2021年:用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)
・心臓マーカーの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・心臓マーカーのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・心臓マーカーのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・心臓マーカーの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・心臓マーカー市場の成長要因・課題・動向
・心臓マーカーの世界市場予測 2021年-2026年
・心臓マーカーの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・心臓マーカーのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・心臓マーカーのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・心臓マーカーの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・心臓マーカーの世界市場予測:種類別(クレアチンキナーゼ(CK)MB、トロポニン(cTnI・cTnT)、BNP・NT-proBNP、ミオグロブリン、その他(hs-CRP、D-ダイマー))
・心臓マーカーの世界市場予測:用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Cardiac Marker will have significant change from previous year. By the most conservative estimates of global Cardiac Marker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiac Marker market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Marker market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
HyTest
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
Trinity Biotech
Sunfory
Lee BioSolutions

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiac Marker Consumption 2016-2026
2.1.2 Cardiac Marker Consumption CAGR by Region
2.2 Cardiac Marker Segment by Type
2.2.1 Creatine kinase (CK) MB
2.2.2 Troponin (cTnI and cTnT)
2.2.3 BNP & NT-proBNP
2.2.4 Myogloblin
2.2.5 Others (hs-CRP, D-Dimer, etc.)
2.3 Cardiac Marker Sales by Type
2.3.1 Global Cardiac Marker Sales Market Share by Type (2016-2021)
2.3.2 Global Cardiac Marker Revenue and Market Share by Type (2016-2021)
2.3.3 Global Cardiac Marker Sale Price by Type (2016-2021)
2.4 Cardiac Marker Segment by Application
2.4.1 Myocardial Infarction
2.4.2 Congestive Heart Failure
2.4.3 Acute Coronary Syndrome
2.4.4 Atherosclerosis
2.4.5 Others
2.5 Cardiac Marker Sales by Application
2.5.1 Global Cardiac Marker Sale Market Share by Application (2016-2021)
2.5.2 Global Cardiac Marker Revenue and Market Share by Application (2016-2021)
2.5.3 Global Cardiac Marker Sale Price by Application (2016-2021)

3 Global Cardiac Marker by Company
3.1 Global Cardiac Marker Sales Market Share by Company
3.1.1 Global Cardiac Marker Sales by Company (2019-2021)
3.1.2 Global Cardiac Marker Sales Market Share by Company (2019-2021)
3.2 Global Cardiac Marker Revenue Market Share by Company
3.2.1 Global Cardiac Marker Revenue by Company (2019-2021)
3.2.2 Global Cardiac Marker Revenue Market Share by Company (2019-2021)
3.3 Global Cardiac Marker Sale Price by Company
3.4 Global Manufacturers Cardiac Marker Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiac Marker Product Location Distribution
3.4.2 Players Cardiac Marker Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cardiac Marker by Region
4.1 Global Cardiac Marker by Region
4.1.1 Global Cardiac Marker Sales by Region
4.1.2 Global Cardiac Marker Revenue by Region
4.2 Americas Cardiac Marker Sales Growth
4.3 APAC Cardiac Marker Sales Growth
4.4 Europe Cardiac Marker Sales Growth
4.5 Middle East & Africa Cardiac Marker Sales Growth

5 Americas
5.1 Americas Cardiac Marker Sales by Country
5.1.1 Americas Cardiac Marker Sales by Country (2016-2021)
5.1.2 Americas Cardiac Marker Revenue by Country (2016-2021)
5.2 Americas Cardiac Marker Sales by Type
5.3 Americas Cardiac Marker Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cardiac Marker Sales by Region
6.1.1 APAC Cardiac Marker Sales by Region (2016-2021)
6.1.2 APAC Cardiac Marker Revenue by Region (2016-2021)
6.2 APAC Cardiac Marker Sales by Type
6.3 APAC Cardiac Marker Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cardiac Marker by Country
7.1.1 Europe Cardiac Marker Sales by Country (2016-2021)
7.1.2 Europe Cardiac Marker Revenue by Country (2016-2021)
7.2 Europe Cardiac Marker Sales by Type
7.3 Europe Cardiac Marker Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cardiac Marker by Country
8.1.1 Middle East & Africa Cardiac Marker Sales by Country (2016-2021)
8.1.2 Middle East & Africa Cardiac Marker Revenue by Country (2016-2021)
8.2 Middle East & Africa Cardiac Marker Sales by Type
8.3 Middle East & Africa Cardiac Marker Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cardiac Marker Distributors
10.3 Cardiac Marker Customer

11 Global Cardiac Marker Market Forecast
11.1 Global Cardiac Marker Forecast by Region
11.1.1 Global Cardiac Marker Forecast by Regions (2021-2026)
11.2.2 Global Cardiac Marker Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Cardiac Marker Forecast by Type
11.7 Global Cardiac Marker Forecast by Application

12 Key Players Analysis
12.1 HyTest
12.1.1 HyTest HyTest Company Information
12.1.2 HyTest Cardiac Marker Product Offered
12.1.3 HyTest Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 HyTest Main Business Overview
12.1.5 HyTest Latest Developments
12.2 Abbott
12.2.1 Abbott Company Information
12.2.2 Abbott Cardiac Marker Product Offered
12.2.3 Abbott Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Abbott Main Business Overview
12.2.5 Abbott Latest Developments
12.3 Roche Diagnostics
12.3.1 Roche Diagnostics Company Information
12.3.2 Roche Diagnostics Cardiac Marker Product Offered
12.3.3 Roche Diagnostics Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Roche Diagnostics Main Business Overview
12.3.5 Roche Diagnostics Latest Developments
12.4 BG Medicine
12.4.1 BG Medicine Company Information
12.4.2 BG Medicine Cardiac Marker Product Offered
12.4.3 BG Medicine Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 BG Medicine Main Business Overview
12.4.5 BG Medicine Latest Developments
12.5 Biomerieux
12.5.1 Biomerieux Company Information
12.5.2 Biomerieux Cardiac Marker Product Offered
12.5.3 Biomerieux Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Biomerieux Main Business Overview
12.5.5 Biomerieux Latest Developments
12.6 Critical Diagnostics
12.6.1 Critical Diagnostics Company Information
12.6.2 Critical Diagnostics Cardiac Marker Product Offered
12.6.3 Critical Diagnostics Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Critical Diagnostics Main Business Overview
12.6.5 Critical Diagnostics Latest Developments
12.7 DiaDexus
12.7.1 DiaDexus Company Information
12.7.2 DiaDexus Cardiac Marker Product Offered
12.7.3 DiaDexus Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 DiaDexus Main Business Overview
12.7.5 DiaDexus Latest Developments
12.8 Response Biomedical
12.8.1 Response Biomedical Company Information
12.8.2 Response Biomedical Cardiac Marker Product Offered
12.8.3 Response Biomedical Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Response Biomedical Main Business Overview
12.8.5 Response Biomedical Latest Developments
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Company Information
12.9.2 Siemens Healthcare Cardiac Marker Product Offered
12.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Siemens Healthcare Main Business Overview
12.9.5 Siemens Healthcare Latest Developments
12.10 Singulex
12.10.1 Singulex Company Information
12.10.2 Singulex Cardiac Marker Product Offered
12.10.3 Singulex Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Singulex Main Business Overview
12.10.5 Singulex Latest Developments
12.11 Thermo Scientific
12.11.1 Thermo Scientific Company Information
12.11.2 Thermo Scientific Cardiac Marker Product Offered
12.11.3 Thermo Scientific Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Thermo Scientific Main Business Overview
12.11.5 Thermo Scientific Latest Developments
12.12 Trinity Biotech
12.12.1 Trinity Biotech Company Information
12.12.2 Trinity Biotech Cardiac Marker Product Offered
12.12.3 Trinity Biotech Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Trinity Biotech Main Business Overview
12.12.5 Trinity Biotech Latest Developments
12.13 Sunfory
12.13.1 Sunfory Company Information
12.13.2 Sunfory Cardiac Marker Product Offered
12.13.3 Sunfory Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Sunfory Main Business Overview
12.13.5 Sunfory Latest Developments
12.14 Lee BioSolutions
12.14.1 Lee BioSolutions Company Information
12.14.2 Lee BioSolutions Cardiac Marker Product Offered
12.14.3 Lee BioSolutions Cardiac Marker Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Lee BioSolutions Main Business Overview
12.14.5 Lee BioSolutions Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Cardiac Marker Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Creatine kinase (CK) MB
Table 3. Major Players of Troponin (cTnI and cTnT)
Table 4. Major Players of BNP & NT-proBNP
Table 5. Major Players of Myogloblin
Table 6. Major Players of Others (hs-CRP, D-Dimer, etc.)
Table 7. Global Cardiac Marker Sales by Type (2016-2021) & (K Doses)
Table 8. Global Cardiac Marker Sales Market Share by Type (2016-2021)
Table 9. Global Cardiac Marker Revenue by Type (2016-2021) & ($ million)
Table 10. Global Cardiac Marker Revenue Market Share by Type (2016-2021)
Table 11. Global Cardiac Marker Sale Price by Type (2016-2021)
Table 12. Global Cardiac Marker Sales by Application (2016-2021) & (K Doses)
Table 13. Global Cardiac Marker Sales Market Share by Application (2016-2021)
Table 14. Global Cardiac Marker Value by Application (2016-2021)
Table 15. Global Cardiac Marker Revenue Market Share by Application (2016-2021)
Table 16. Global Cardiac Marker Sale Price by Application (2016-2021)
Table 17. Global Cardiac Marker Sales by Company (2019-2021) & (K Doses)
Table 18. Global Cardiac Marker Sales Market Share by Company (2019-2021)
Table 19. Global Cardiac Marker Revenue by Company (2019-2021) ($ Millions)
Table 20. Global Cardiac Marker Revenue Market Share by Company (2019-2021)
Table 21. Global Cardiac Marker Sale Price by Company (2019-2021)
Table 22. Key Manufacturers Cardiac Marker Producing Area Distribution and Sales Area
Table 23. Players Cardiac Marker Products Offered
Table 24. Cardiac Marker Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cardiac Marker Sales by Region (2016-2021) (K Doses)
Table 28. Global Cardiac Marker Sales Market Share by Region (2016-2021)
Table 29. Global Cardiac Marker Revenue by Region (2016-2021) & ($ Millions)
Table 30. Global Cardiac Marker Revenue Market Share by Region (2016-2021)
Table 31. Americas Cardiac Marker Sales by Country (2016-2021) & (K Doses)
Table 32. Americas Cardiac Marker Sales Market Share by Country (2016-2021)
Table 33. Americas Cardiac Marker Revenue by Country (2016-2021) & ($ Millions)
Table 34. Americas Cardiac Marker Revenue Market Share by Country (2016-2021)
Table 35. Americas Cardiac Marker Sales by Type (2016-2021) & (K Doses)
Table 36. Americas Cardiac Marker Sales Market Share by Type (2016-2021)
Table 37. Americas Cardiac Marker Sales by Application (2016-2021) & (K Doses)
Table 38. Americas Cardiac Marker Sales Market Share by Application (2016-2021)
Table 39. APAC Cardiac Marker Sales by Region (2016-2021) & (K Doses)
Table 40. APAC Cardiac Marker Sales Market Share by Region (2016-2021)
Table 41. APAC Cardiac Marker Revenue by Region (2016-2021) & ($ Millions)
Table 42. APAC Cardiac Marker Revenue Market Share by Region (2016-2021)
Table 43. APAC Cardiac Marker Sales by Type (2016-2021) & (K Doses)
Table 44. APAC Cardiac Marker Sales Market Share by Type (2016-2021)
Table 45. APAC Cardiac Marker Sales by Application (2016-2021) & (K Doses)
Table 46. APAC Cardiac Marker Sales Market Share by Application (2016-2021)
Table 47. Europe Cardiac Marker Sales by Country (2016-2021) & (K Doses)
Table 48. Europe Cardiac Marker Sales Market Share by Country (2016-2021)
Table 49. Europe Cardiac Marker Revenue by Country (2016-2021) & ($ Millions)
Table 50. Europe Cardiac Marker Revenue Market Share by Country (2016-2021)
Table 51. Europe Cardiac Marker Sales by Type (2016-2021) & (K Doses)
Table 52. Europe Cardiac Marker Sales Market Share by Type (2016-2021)
Table 53. Europe Cardiac Marker Sales by Application (2016-2021) & (K Doses)
Table 54. Europe Cardiac Marker Sales Market Share by Application (2016-2021)
Table 55. Middle East & Africa Cardiac Marker Sales by Country (2016-2021) & (K Doses)
Table 56. Middle East & Africa Cardiac Marker Sales Market Share by Country (2016-2021)
Table 57. Middle East & Africa Cardiac Marker Revenue by Country (2016-2021) & ($ Millions)
Table 58. Middle East & Africa Cardiac Marker Revenue Market Share by Country (2016-2021)
Table 59. Middle East & Africa Cardiac Marker Sales by Type (2016-2021) & (K Doses)
Table 60. Middle East & Africa Cardiac Marker Sales Market Share by Type (2016-2021)
Table 61. Middle East & Africa Cardiac Marker Sales by Application (2016-2021) & (K Doses)
Table 62. Middle East & Africa Cardiac Marker Sales Market Share by Application (2016-2021)
Table 63. Global Cardiac Marker Sales Forecast by Type (2021-2026) & (K Doses)
Table 64. Global Cardiac Marker Sales Market Share Forecast by Type (2021-2026)
Table 65. Global Cardiac Marker Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 66. Global Cardiac Marker Revenue Market Share Forecast by Type (2021-2026)
Table 67. Global Cardiac Marker Sales Forecast by Application (2021-2026) & (K Doses)
Table 68. Global Cardiac Marker Sales Market Share Forecast by Application (2021-2026)
Table 69. Global Cardiac Marker Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 70. Global Cardiac Marker Revenue Market Share Forecast by Application (2021-2026)
Table 71. HyTest Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 72. HyTest Cardiac Marker Product Offered
Table 73. HyTest Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 74. HyTest Main Business
Table 75. HyTest Latest Developments
Table 76. Abbott Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 77. Abbott Cardiac Marker Product Offered
Table 78. Abbott Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 79. Abbott Main Business
Table 80. Abbott Latest Developments
Table 81. Roche Diagnostics Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 82. Roche Diagnostics Cardiac Marker Product Offered
Table 83. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 84. Roche Diagnostics Main Business
Table 85. Roche Diagnostics Latest Developments
Table 86. BG Medicine Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 87. BG Medicine Cardiac Marker Product Offered
Table 88. BG Medicine Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 89. BG Medicine Main Business
Table 90. BG Medicine Latest Developments
Table 91. Biomerieux Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 92. Biomerieux Cardiac Marker Product Offered
Table 93. Biomerieux Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 94. Biomerieux Main Business
Table 95. Biomerieux Latest Developments
Table 96. Critical Diagnostics Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 97. Critical Diagnostics Cardiac Marker Product Offered
Table 98. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 99. Critical Diagnostics Main Business
Table 100. Critical Diagnostics Latest Developments
Table 101. DiaDexus Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 102. DiaDexus Cardiac Marker Product Offered
Table 103. DiaDexus Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 104. DiaDexus Main Business
Table 105. DiaDexus Latest Developments
Table 106. Response Biomedical Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 107. Response Biomedical Cardiac Marker Product Offered
Table 108. Response Biomedical Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 109. Response Biomedical Main Business
Table 110. Response Biomedical Latest Developments
Table 111. Siemens Healthcare Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 112. Siemens Healthcare Cardiac Marker Product Offered
Table 113. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 114. Siemens Healthcare Main Business
Table 115. Siemens Healthcare Latest Developments
Table 116. Singulex Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 117. Singulex Cardiac Marker Product Offered
Table 118. Singulex Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 119. Singulex Main Business
Table 120. Singulex Latest Developments
Table 121. Thermo Scientific Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 122. Thermo Scientific Cardiac Marker Product Offered
Table 123. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 124. Thermo Scientific Main Business
Table 125. Thermo Scientific Latest Developments
Table 126. Trinity Biotech Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 127. Trinity Biotech Cardiac Marker Product Offered
Table 128. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 129. Trinity Biotech Main Business
Table 130. Trinity Biotech Latest Developments
Table 131. Sunfory Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 132. Sunfory Cardiac Marker Product Offered
Table 133. Sunfory Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 134. Sunfory Main Business
Table 135. Sunfory Latest Developments
Table 136. Lee BioSolutions Basic Information, Cardiac Marker Manufacturing Base, Sales Area and Its Competitors
Table 137. Lee BioSolutions Cardiac Marker Product Offered
Table 138. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 139. Lee BioSolutions Main Business
Table 140. Lee BioSolutions Latest Developments
List of Figures
Figure 1. Picture of Cardiac Marker
Figure 2. Cardiac Marker Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiac Marker Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Cardiac Marker Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Cardiac Marker Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Creatine kinase (CK) MB
Figure 10. Product Picture of Troponin (cTnI and cTnT)
Figure 11. Product Picture of BNP & NT-proBNP
Figure 12. Product Picture of Myogloblin
Figure 13. Product Picture of Others (hs-CRP, D-Dimer, etc.)
Figure 14. Global Cardiac Marker Sales Market Share by Type in 2020
Figure 15. Global Cardiac Marker Revenue Market Share by Type (2016-2021)
Figure 16. Cardiac Marker Consumed in Myocardial Infarction
Figure 17. Global Cardiac Marker Market: Myocardial Infarction (2016-2021) & (K Doses)
Figure 18. Cardiac Marker Consumed in Congestive Heart Failure
Figure 19. Global Cardiac Marker Market: Congestive Heart Failure (2016-2021) & (K Doses)
Figure 20. Cardiac Marker Consumed in Acute Coronary Syndrome
Figure 21. Global Cardiac Marker Market: Acute Coronary Syndrome (2016-2021) & (K Doses)
Figure 22. Cardiac Marker Consumed in Atherosclerosis
Figure 23. Global Cardiac Marker Market: Atherosclerosis (2016-2021) & (K Doses)
Figure 24. Cardiac Marker Consumed in Others
Figure 25. Global Cardiac Marker Market: Others (2016-2021) & (K Doses)
Figure 26. Global Cardiac Marker Sales Market Share by Application (2016-2021)
Figure 27. Global Cardiac Marker Revenue Market Share by Application in 2020
Figure 28. Global Cardiac Marker Revenue Market by Company in 2020 ($ Million)
Figure 29. Global Cardiac Marker Revenue Market Share by Company in 2020
Figure 30. Global Cardiac Marker Sales Market Share by Regions (2016-2021)
Figure 31. Global Cardiac Marker Revenue Market Share by Region in 2020
Figure 32. Americas Cardiac Marker Sales 2016-2021 (K Doses)
Figure 33. Americas Cardiac Marker Revenue 2016-2021 ($ Millions)
Figure 34. APAC Cardiac Marker Sales 2016-2021 (K Doses)
Figure 35. APAC Cardiac Marker Revenue 2016-2021 ($ Millions)
Figure 36. Europe Cardiac Marker Sales 2016-2021 (K Doses)
Figure 37. Europe Cardiac Marker Revenue 2016-2021 ($ Millions)
Figure 38. Middle East & Africa Cardiac Marker Sales 2016-2021 (K Doses)
Figure 39. Middle East & Africa Cardiac Marker Revenue 2016-2021 ($ Millions)
Figure 40. Americas Cardiac Marker Sales Market Share by Country in 2020
Figure 41. Americas Cardiac Marker Revenue Market Share by Country in 2020
Figure 42. Americas Cardiac Marker Sales Market Share by Type in 2020
Figure 43. Americas Cardiac Marker Sales Market Share by Application in 2020
Figure 44. United States Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 45. Canada Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 46. Mexico Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 47. Brazil Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 48. APAC Cardiac Marker Sales Market Share by Region in 2020
Figure 49. APAC Cardiac Marker Revenue Market Share by Regions in 2020
Figure 50. APAC Cardiac Marker Sales Market Share by Type in 2020
Figure 51. APAC Cardiac Marker Sales Market Share by Application in 2020
Figure 52. China Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 53. Japan Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 54. Korea Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 55. Southeast Asia Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 56. India Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 57. Australia Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 58. Europe Cardiac Marker Sales Market Share by Country in 2020
Figure 59. Europe Cardiac Marker Revenue Market Share by Country in 2020
Figure 60. Europe Cardiac Marker Sales Market Share by Type in 2020
Figure 61. Europe Cardiac Marker Sales Market Share by Application in 2020
Figure 62. Germany Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 63. France Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 64. UK Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 65. Italy Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 66. Russia Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 67. Middle East & Africa Cardiac Marker Sales Market Share by Country in 2020
Figure 68. Middle East & Africa Cardiac Marker Revenue Market Share by Country in 2020
Figure 69. Middle East & Africa Cardiac Marker Sales Market Share by Type in 2020
Figure 70. Middle East & Africa Cardiac Marker Sales Market Share by Application in 2020
Figure 71. Egypt Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 72. South Africa Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 73. Israel Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 74. Turkey Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 75. GCC Country Cardiac Marker Revenue Growth 2016-2021 ($ Millions)
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles


★調査レポート[世界の心臓マーカー市場予測 2021年-2026年] (コード:LPI21MY9464)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の心臓マーカー市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆